Terns Pharmaceuticals Inc (TERN)

SG&A Expense Growth

11.54%

Quarterly · Period ending:

TERN logo

TERN SG&A Expense Growth

Latest reported11.54%
TERN Quarterly SG&A Growth (QoQ) (0.00% → 11.54%)
High-resolution chart · PNG

TERN sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Terns Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
11.5399%
10.9388%
-19.2604%
9.5909%
-18.6796%
35.9777%
4.7529%
3.94%
-64.044%
161.8864%
-1.3097%
15.0891%
20.2495%
-5.367%
-4.6933%
5.0406%
14.8674%
-2.9236%
6.4898%
357.014%
-70.057%
34.0708%
14.089%
-8.7521%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.